Eqis Capital Management, Inc. View Ray, Inc. Transaction History

Eqis Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.45 - $5.83 $35,790 - $60,480	-10,374 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.89 - $7.59 $50,728 - $78,738	10,374 New	10,374 $57,000
Q3 2021 Nov 12, 2021	SELL	$5.18 - $7.41 $53,840 - $77,019	-10,394 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$3.94 - $6.75 $5,181 - $8,876	-1,315 Reduced 11.23%	10,394 $69,000
Q1 2021 May 14, 2021	BUY	$4.03 - $7.25 $47,187 - $84,890	11,709 New	11,709 $51,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.